Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
2017 · Science · 4,526 citations
https://doi.org/10.1126/science.aan4236
S
Sapna P. Patel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
441
Papers
20.8K
Citations
51
h-index
137
i10-index
Sapna P. Patel is an academic researcher from Maharaja Sayajirao University of Baroda. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research & Melanoma and MAPK Pathways. The author has an h-index of 51, co-authored 375 publications.
ORCID: 0000-0003-1339-1517Papers by this author
worksB cells and tertiary lymphoid structures promote immunotherapy response
2020 · Nature · 2,551 citations
https://doi.org/10.1038/s41586-019-1922-8
Neoadjuvant relatlimab and nivolumab in resectable melanoma
2022 · Nature · 317 citations
https://doi.org/10.1038/s41586-022-05368-8
Advances in the clinical management of uveal melanoma
2023 · Nature Reviews Clinical Oncology · 242 citations
https://doi.org/10.1038/s41571-022-00714-1
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
2022 · Nature · 129 citations
https://doi.org/10.1038/s41586-022-04833-8
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
2023 · Nature Medicine · 72 citations
https://doi.org/10.1038/s41591-022-02170-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat